Use of carbamoyl phosphate synthase 1 (CPS1) as a humoral biomarker for the diagnosis of tumor diseases and chronic inflammatory bowel disease

摘要

The invention relates to the use of carbamoyl synthetase 1 (CPS 1) as a humoral biomarker in in vitro methods for early diagnosis and detection, progress prognosis, the evaluation of the severity, and the progress evaluation of tumor diseases and chronic inflammatory intestinal diseases.